CSAR lecture: Using the very small to tackle the very large
Date: Mon Nov 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time) at 19:30 - 21:00
Location: The Old Divinity School, St. John's College, Cambridge CB2 1TP
Our nanomedicine journey from concept to clinic. Drug development is expensive and risky, with a 0.02% chance of success from concept to the market and with costs of about one billion US dollars. Inadequate efficacy is a major reason for failure and low concentrations of drug at the site of disease contribute to poor effectiveness. An estimated half of patients with chronic conditions do not take their medicines as prescribed due to the fear of side effects. Side effects may be minimised if more
Source: talks-cam